Related Experiment Video
Updated: Feb 23, 2026

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.9K
Validity of Surrogate End Points for Prostate Cancer
1Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
JAMA Oncology
|September 1, 2017
Abstract
No abstract available in PubMed .

